605 related articles for article (PubMed ID: 29140182)
1. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
3. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.
Yuan B; El Dana F; Ly S; Yan Y; Ruvolo V; Shpall EJ; Konopleva M; Andreeff M; Battula VL
PLoS One; 2020; 15(11):e0242809. PubMed ID: 33253299
[TBL] [Abstract][Full Text] [Related]
7. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
[TBL] [Abstract][Full Text] [Related]
8. Effect of TGF-β1/SDF-1/CXCR4 signal on BM-MSCs homing in rat heart of ischemia/perfusion injury.
Zhang SJ; Song XY; He M; Yu SB
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):899-905. PubMed ID: 27010148
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
10. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.
Li X; Guo H; Duan H; Yang Y; Meng J; Liu J; Wang C; Xu H
Sci Rep; 2015 Nov; 5():16228. PubMed ID: 26538086
[TBL] [Abstract][Full Text] [Related]
11. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
[TBL] [Abstract][Full Text] [Related]
12. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4.
Si XY; Li JJ; Yao T; Wu XY
Mol Med Rep; 2014 May; 9(5):1794-8. PubMed ID: 24573381
[TBL] [Abstract][Full Text] [Related]
14. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
15. Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.
Pillozzi S; Bernini A; Spiga O; Lelli B; Petroni G; Bracci L; Niccolai N; Arcangeli A
Oncol Rep; 2019 Jan; 41(1):312-324. PubMed ID: 30365110
[TBL] [Abstract][Full Text] [Related]
16. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
17. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
19. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
[TBL] [Abstract][Full Text] [Related]
20. [Transforming growth factor-β1 induces bone marrow-derived mesenchymal stem cells to differentiate into cancer-associated fibroblasts].
Shangguan L; Li X; Wang Z; Luo Z
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):804-9. PubMed ID: 26887508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]